dr. adams on whether prior lines of therapy impact response to immunotherapy in tnbc
Published 5 years ago • 69 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
0:20
copy of dr. adams on whether prior lines of therapy impact response to immunotherapy in tnbc
-
2:08
dr. adams on immunotherapy in triple-negative breast cancer
-
0:26
copy of dr. adams on immunotherapy in triple-negative breast cancer
-
1:49
dr. adams on combinatorial approaches in triple-negative breast cancer
-
6:01
immunotherapy for triple-negative breast cancer
-
1:37
dr. adams on the utility of combination ctla-4 and pd-1 blockade in breast cancer
-
1:59
dr. andreopoulou on the impact of immunotherapy in tnbc
-
34:50
breast cancer immunotherapy with dr. sylvia adams and victor ty, bsn, rn
-
5:49
immunotherapy for tnbc
-
1:33
dr. sylvia adams on tumor-infiltrating lymphocytes in triple negative breast cancer
-
1:32
dr. disis on immunotherapy in breast cancer
-
1:16
dr. tolaney on platinum-based therapy in neoadjuvant setting of tnbc
-
8:32
immunotherapy for triple-negative breast cancer
-
2:07
tnbc: using checkpoint inhibitors alone or with chemotherapy
-
31:24
harnessing the immune system in the treatment of triple-negative breast cancer
-
2:06
dr. burris on recent advances in tnbc
-
1:52
dr. rugo on recent updates with immunotherapy in tnbc
-
1:28
dr. o'shaughnessy on precision medicine in triple negative breast cancer
-
1:18
dr. carey on treating triple-negative breast cancer